Suppr超能文献

[胰腺酶替代疗法下黏液黏稠病婴儿脂肪和蛋白质的消化及其与粪便酶活性的关系(作者译)]

[Digestion of fat and protein and its relation to the activity of faecal enzymes in mucoviscidosis infants under substitution therapy with pancreatic enzymes (author's transl)].

作者信息

Tolckmitt W, Lohmann A, Kutschera J

出版信息

Klin Padiatr. 1981 Sep;193(5):365-9. doi: 10.1055/s-2008-1034498.

Abstract

The article reports on a study to determine the influence of different dosage schedules of a pancreas enzyme preparation on the digestion of fat and protein and on the lipolytic, tryptic and chymotryptic activity of the faeces in children suffering from mucoviscidose. After administration of the pancreatin preparation at the low dose level, the quantity of faeces, the excretion of fatty acids and of nitrogen are reduced and the absorption coefficient is improved. The faecal tryptic and chymotryptic activity increases, whereas the lipase activity in the faeces merely shows a tendency to rise. Increasing the pancreatin dose up to a still tolerable value by doubling the dosage does not result in further reduction of the excretion of fat and nitrogen although it enhances the proteolytic activity of the faeces while the lipase activity remains unaffected. Determination of the lipolytic, tryptic or chymotryptic activity is, therefore, unsuitable for assessing the fat and protein digestion and for estimating the required dose of pancreatic enzyme. No increase in uric acid excretion was seen in the urine collected for 24 hours after administration of both enzyme doses.

摘要

该文章报道了一项研究,旨在确定胰腺酶制剂的不同给药方案对患有粘多糖病的儿童脂肪和蛋白质消化以及粪便中脂肪分解、胰蛋白酶和糜蛋白酶活性的影响。在低剂量水平给予胰酶制剂后,粪便量、脂肪酸和氮的排泄减少,吸收系数提高。粪便中胰蛋白酶和糜蛋白酶活性增加,而粪便中的脂肪酶活性仅呈现上升趋势。将胰酶剂量加倍至仍可耐受的值,虽然会增强粪便的蛋白水解活性且脂肪酶活性不受影响,但不会导致脂肪和氮排泄的进一步减少。因此,测定脂肪分解、胰蛋白酶或糜蛋白酶活性不适用于评估脂肪和蛋白质消化以及估计所需的胰腺酶剂量。给予两种酶剂量后,收集的24小时尿液中尿酸排泄未见增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验